DE60239752D1 - Den geschmack verdeckende auslaufsichere formulierung - Google Patents

Den geschmack verdeckende auslaufsichere formulierung

Info

Publication number
DE60239752D1
DE60239752D1 DE60239752T DE60239752T DE60239752D1 DE 60239752 D1 DE60239752 D1 DE 60239752D1 DE 60239752 T DE60239752 T DE 60239752T DE 60239752 T DE60239752 T DE 60239752T DE 60239752 D1 DE60239752 D1 DE 60239752D1
Authority
DE
Germany
Prior art keywords
taste
protective formulation
related protective
base
pharmaceutical agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239752T
Other languages
English (en)
Inventor
Daniel A Moros
Shen Gao
Maxine G Moldenhauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taro Pharmaceutical Industries Ltd
Original Assignee
Taro Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceutical Industries Ltd filed Critical Taro Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE60239752D1 publication Critical patent/DE60239752D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60239752T 2001-10-22 2002-10-22 Den geschmack verdeckende auslaufsichere formulierung Expired - Lifetime DE60239752D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33044701P 2001-10-22 2001-10-22
PCT/US2002/033478 WO2003034991A2 (en) 2001-10-22 2002-10-22 Taste masking spill-resistant formulation

Publications (1)

Publication Number Publication Date
DE60239752D1 true DE60239752D1 (de) 2011-05-26

Family

ID=23289820

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239752T Expired - Lifetime DE60239752D1 (de) 2001-10-22 2002-10-22 Den geschmack verdeckende auslaufsichere formulierung

Country Status (12)

Country Link
EP (1) EP1438026B1 (de)
JP (3) JP2005506993A (de)
KR (1) KR20040084891A (de)
CN (1) CN1571661A (de)
AT (1) ATE505183T1 (de)
AU (1) AU2002356831B2 (de)
BR (1) BR0213379A (de)
CA (2) CA2764642A1 (de)
DE (1) DE60239752D1 (de)
IL (2) IL161500A0 (de)
MX (1) MXPA04003789A (de)
WO (1) WO2003034991A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5398100B2 (ja) * 2003-06-23 2014-01-29 大正製薬株式会社 鉄化合物を含む内服液剤組成物
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
JP2009510003A (ja) * 2005-09-30 2009-03-12 ディーエスエム アイピー アセッツ ビー．ブイ． ポリフェノールを含有する新規の組成物
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP5155883B2 (ja) * 2006-01-25 2013-03-06 ターロ ファーマシューティカルズ ノース アメリカ インコーポレイテッド 抗ヒスタミン組成物及びその使用
EP2313083A1 (de) * 2008-07-22 2011-04-27 Lupin Limited Orale zusammensetzungen von clindamycin
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
ES2569925T3 (es) 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
EP2968573A1 (de) * 2013-03-15 2016-01-20 Novartis Consumer Health, Inc. Farbstofffreie flüssige therapeutische lösung
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA3045118A1 (en) 2016-11-28 2018-05-31 Johnson & Johnson Consumer Inc. Liquid compositions comprising a mucoadhesive agent
NL2024161B1 (en) * 2019-11-05 2021-07-20 Mperium B V Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法
EP4368171A1 (de) * 2022-11-08 2024-05-15 Laboratorios Ern S.A. Orale paracetamollösung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6010683A (en) * 1997-11-05 2000-01-04 Ultradent Products, Inc. Compositions and methods for reducing the quantity but not the concentration of active ingredients delivered by a dentifrice
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form

Also Published As

Publication number Publication date
WO2003034991A2 (en) 2003-05-01
EP1438026B1 (de) 2011-04-13
EP1438026A4 (de) 2005-08-03
MXPA04003789A (es) 2005-06-03
AU2002356831B2 (en) 2006-06-08
CA2764642A1 (en) 2003-05-01
BR0213379A (pt) 2005-02-01
IL161500A0 (en) 2004-09-27
JP2005506993A (ja) 2005-03-10
CA2466036A1 (en) 2003-05-01
IL161500A (en) 2012-10-31
CN1571661A (zh) 2005-01-26
JP2009102389A (ja) 2009-05-14
KR20040084891A (ko) 2004-10-06
EP1438026A2 (de) 2004-07-21
JP2013014626A (ja) 2013-01-24
CA2466036C (en) 2012-04-24
JP5185844B2 (ja) 2013-04-17
ATE505183T1 (de) 2011-04-15
WO2003034991A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
DE60239752D1 (de) Den geschmack verdeckende auslaufsichere formulierung
WO2005065646A3 (en) Novel drug compositions and dosage forms
NO20061840L (no) Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
LU92060I2 (fr) Interféron beta-1a
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
DK0762896T3 (da) Tocopherol-sammensætninger til levering af biologisk aktive stoffer
TR200100671T1 (tr) Antiviral indoloksoasetil piperazin türevleri
MY129406A (en) Taste masked liquid pharmaceutical compositions
IS2863B (is) Arípíprazóllausn til gjafar um munn
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
DE69940635D1 (de) Copolymer-zusammensetzungen zur oralen verabreichung
DE60019334D1 (de) Antivirale arznei
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
ATE230258T1 (de) Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin
SE0001916D0 (sv) Novel formulation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
GEP20043377B (en) Pharmaceutical Complex
HK1068344A1 (en) Dimeric compounds and their use as anti-viral agents
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
BR0213463A (pt) Composições farmacêuticas contendo macrólidos